Nova Leap Health Reports Q3 2026 Revenue Growth and Increased Adjusted EBITDA
Nova Leap Health (NLH:CA) has released its third-quarter financial results, reporting a total revenue of $9.53 billion. This represents a 15.3% increase compared to the same period in the previous year, driven by an organic revenue growth rate of 8.2%. The company also demonstrated significant improvements in profitability, with Adjusted EBITDA rising to $860.80K. This marks a 28.3% increase over the Q3 2025 Adjusted EBITDA of $670.71K, signaling strong operational efficiency and margin expansion.
Tickers: $NVLPF
Topics: EBITDA financial results revenue growth